Back to rounds

Company profile

pantarg

PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.

Location
Copenhagen, Hovedstaden, Denmark, Europe
Website
pantarg.com

Latest known funding

Pre-Seed round

Capital
$1.5M
Announced
Sep 7, 2026

Participating investors